KP Management LLC Reduces Holdings in Danaher Co. (NYSE:DHR)

KP Management LLC lowered its position in Danaher Co. (NYSE:DHR - Free Report) by 8.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 17,000 shares of the conglomerate's stock after selling 1,500 shares during the period. KP Management LLC's holdings in Danaher were worth $3,902,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher during the fourth quarter worth about $31,000. Golden State Wealth Management LLC purchased a new position in Danaher during the fourth quarter worth about $31,000. Hurley Capital LLC acquired a new position in Danaher in the 4th quarter valued at about $34,000. Finally, Pineridge Advisors LLC grew its stake in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Trading Up 0.4 %

Shares of DHR stock opened at $197.37 on Friday. The business's fifty day moving average price is $200.87 and its 200 day moving average price is $224.27. The firm has a market capitalization of $141.06 billion, a PE ratio of 37.38, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were issued a $0.32 dividend. The ex-dividend date was Friday, March 28th. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's payout ratio is 24.85%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Citigroup reiterated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Jefferies Financial Group dropped their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Wells Fargo & Company decreased their price objective on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Finally, Guggenheim reiterated a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $264.40.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.